Developing and validating a Chinese multimorbidity-weighted index for middle-aged and older community-dwelling individuals

纵向研究 日常生活活动 医学 老年学 阿卡克信息准则 索引(排版) 巴氏指数 人口学 物理疗法 统计 数学 病理 社会学 万维网 计算机科学
作者
Weihua Hu,Yuyang Liu,Conghui Yang,Zhou Tong,Chun Yang,Ying‐Si Lai,Jing Liao,Yuantao Hao
出处
期刊:Age and Ageing [Oxford University Press]
卷期号:51 (2) 被引量:48
标识
DOI:10.1093/ageing/afab274
摘要

OBJECTIVE: To develop and validate an index to quantify the multimorbidity burden in Chinese middle-aged and older community-dwelling individuals. METHODS: We included 20,035 individuals aged 45 and older from the China Health and Retirement Longitudinal Study (CHARLS) and 19,297 individuals aged 65 and older from the Chinese Longitudinal Healthy Longevity Survey (CLHLS). Health outcomes of physical functioning (PF), basic and instrumental activities of daily living (ADL and IADL) and mortality were obtained. Based on self-reported disease status, we calculated five commonly used western multimorbidity indexes for CHARLS baseline participants. The one that predicted the health outcomes the best was selected and then modified through a linear mixed model using the repeated individual data in CHARLS. The performance of the modified index was internally and externally evaluated with CHARLS and CLHLS data. RESULTS: The multimorbidity-weighted index (MWI) performed the best among the five indexes. In the modified Chinese multimorbidity-weighted index (CMWI), the weights of the diseases varied greatly (range 0.2-5.1). The top three diseases with the highest impact were stroke, memory-related diseases and cancer, corresponding to weights of 5.1, 4.3 and 3.4, respectively. Compared with the MWI, the CMWI showed better model fits for PF and IADL with larger R2 and smaller Akaike information criterion, and comparable prediction performances for ADL, IADL and mortality (e.g. the same predictive accuracy of 0.80 for ADL disability). CONCLUSION: The CMWI is an adequate index to quantify the multimorbidity burden for Chinese middle-aged and older community-dwelling individuals. It can be directly computed via disease status examined in regular community health check-ups to facilitate health management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
肖不错发布了新的文献求助10
刚刚
上官若男应助zcy123采纳,获得10
刚刚
1秒前
顾君如发布了新的文献求助10
1秒前
woqu完成签到 ,获得积分10
1秒前
2秒前
寒冷的映菱完成签到,获得积分10
2秒前
ksrcc发布了新的文献求助10
2秒前
3秒前
3秒前
3秒前
lianqing发布了新的文献求助10
3秒前
3秒前
4秒前
YOLO完成签到,获得积分20
4秒前
Jasper应助孤独巡礼采纳,获得10
4秒前
4秒前
自由月亮完成签到,获得积分10
4秒前
5秒前
ou完成签到,获得积分10
5秒前
小荷完成签到,获得积分10
5秒前
5秒前
5秒前
5秒前
mofei发布了新的文献求助10
5秒前
5秒前
zhw完成签到,获得积分10
5秒前
科研通AI2S应助月亮采纳,获得10
6秒前
千崧发布了新的文献求助10
6秒前
drchen发布了新的文献求助10
6秒前
Alyssa发布了新的文献求助10
7秒前
7秒前
7秒前
离殇完成签到,获得积分10
7秒前
7秒前
7秒前
完美世界应助曲奇饼干采纳,获得10
8秒前
8秒前
8秒前
舒心糖豆发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6958062
求助须知:如何正确求助?哪些是违规求助? 8641168
关于积分的说明 18325009
捐赠科研通 6404949
什么是DOI,文献DOI怎么找? 3084634
关于科研通互助平台的介绍 2132046
邀请新用户注册赠送积分活动 2061264